These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24389597)

  • 1. Pharmacodynamic comparison of pitavastatin versus atorvastatin on platelet reactivity in patients with coronary artery disease treated with dual antiplatelet therapy.
    Pelliccia F; Rosano G; Marazzi G; Vitale C; Spoletini I; Franzoni F; Speziale G; Polacco M; Greco C; Gaudio C
    Circ J; 2014; 78(3):679-84. PubMed ID: 24389597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic effects of atorvastatin versus rosuvastatin in coronary artery disease patients with normal platelet reactivity while on dual antiplatelet therapy--the PEARL randomized cross-over study.
    Pelliccia F; Rosano G; Marazzi G; Vitale C; Spoletini I; Franzoni F; Speziale G; Polacco M; Greco C; Gaudio C
    Eur J Pharmacol; 2014 Feb; 725():18-22. PubMed ID: 24444439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study.
    Leoncini M; Toso A; Maioli M; Angiolillo DJ; Giusti B; Marcucci R; Abbate R; Bellandi F
    JACC Cardiovasc Interv; 2013 Feb; 6(2):169-79. PubMed ID: 23428009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.
    Park Y; Jeong YH; Tantry US; Ahn JH; Kwon TJ; Park JR; Hwang SJ; Gho EH; Bliden KP; Kwak CH; Hwang JY; Kim S; Gurbel PA
    Eur Heart J; 2012 Sep; 33(17):2151-62. PubMed ID: 22507978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet reactivity and clinical outcomes in patients using CYP3A4-metabolized statins with clopidogrel in percutaneous coronary intervention.
    Park JS; Cha KS; Lee HW; Oh JH; Choi JH; Lee HC; Hong TJ; Kim HS;
    Heart Vessels; 2017 Jun; 32(6):690-699. PubMed ID: 27904973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
    Saw J; Steinhubl SR; Berger PB; Kereiakes DJ; Serebruany VL; Brennan D; Topol EJ;
    Circulation; 2003 Aug; 108(8):921-4. PubMed ID: 12925453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.
    Trenk D; Hochholzer W; Frundi D; Stratz C; Valina CM; Bestehorn HP; Büttner HJ; Neumann FJ
    Thromb Haemost; 2008 Jan; 99(1):174-81. PubMed ID: 18217151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dual antiplatelet therapy prescribed as one-pill versus two-pill regimen. A pooled analysis of individual patient data from the three MR-CAPCIS trials.
    Lim WH; Chae IH; Yoon CH; Choi DJ; Lim SW; Park WJ; Doh JH; Kim SH; Kim MA; Lee SH; Yoon JH; Ahn YK; Hyon MS; Kim KS; Kim YK; Lee HC; Seol SH; Hwang KK; Choi SW; Han KR; Shin ES; Kim SW; Lee BK; Kim HS
    Thromb Haemost; 2016 Jul; 116(1):78-86. PubMed ID: 27029284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic effects of adjunctive high dose atorvastatin on double dose clopidogrel in patients with high on-treatment platelet reactivity depending on diabetes mellitus status.
    Leoncini M; Toso A; Maioli M; Angiolillo DJ; Giusti B; Marcucci R; Abbate R; Bellandi F
    J Thromb Thrombolysis; 2014 May; 37(4):427-34. PubMed ID: 23852152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.
    Saw J; Brennan DM; Steinhubl SR; Bhatt DL; Mak KH; Fox K; Topol EJ;
    J Am Coll Cardiol; 2007 Jul; 50(4):291-5. PubMed ID: 17659194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between statin type and responsiveness to clopidogrel in patients treated with percutaneous coronary intervention: a subgroup analysis of the CILON-T trial.
    Suh JW; Cha MJ; Lee SP; Chae IH; Bae JH; Kwon TG; Bae JW; Cho MC; Rha SW; Kim HS
    J Atheroscler Thromb; 2014; 21(2):140-50. PubMed ID: 24140730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation inhibition in patients receiving statins either fully or partially metabolized by CYP3A4.
    Polena S; Gupta MP; Shaikh H; Zazzali K; Coplan N; Gintautas J; Labana SS; Soffer D
    Proc West Pharmacol Soc; 2008; 51():60-2. PubMed ID: 19544679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.
    Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H;
    J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting.
    Gorchakova O; von Beckerath N; Gawaz M; Mocz A; Joost A; Schömig A; Kastrati A
    Eur Heart J; 2004 Nov; 25(21):1898-902. PubMed ID: 15522468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease.
    Vinholt P; Poulsen TS; Korsholm L; Kristensen SR; Hallas J; Damkier P; Mickley H
    Thromb Haemost; 2005 Aug; 94(2):438-43. PubMed ID: 16113837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy.
    Geisler T; Zürn C; Paterok M; Göhring-Frischholz K; Bigalke B; Stellos K; Seizer P; Kraemer BF; Dippon J; May AE; Herdeg C; Gawaz M
    Eur Heart J; 2008 Jul; 29(13):1635-43. PubMed ID: 18503057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive medical therapy alone is not adequate in certain patients with severe symptomatic carotid stenosis.
    Brown MM
    Stroke; 2013 Oct; 44(10):2955-6. PubMed ID: 24046010
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the pharmacodynamic effects of ranolazine versus amlodipine on platelet reactivity in stable patients with coronary artery disease treated with dual antiplatelet therapy : The ROMAN (RanOlazine vs. aMlodipine on platelet reactivity in stable patients with CAD treated with dual ANtiplatelet therapy) study.
    Pelliccia F; Greco C; Gaudio C; Rosano G; Vitale C; Marazzi G; Rollini F; Angiolillo DJ
    J Thromb Thrombolysis; 2015 Oct; 40(3):331-9. PubMed ID: 25761430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.